Abstract
We provide genetic evidence supporting the identity of the candidate gene for BRCA1 through the characterization of germline mutations in 63 breast cancer patients and 10 ovarian cancer patients in ten families with cancer linked to chromosome 17q21. Nine different mutations were detected by screening BRCA1 DNA and RNA by single-strand conformation polymorphism analysis and direct sequencing. Seven mutations lead to protein truncations at sites throughout the gene. One missense mutation (which occurred independently in two families) leads to loss of a cysteine in the zinc binding domain. An intronic single basepair substitution destroys an acceptor site and activates a cryptic splice site, leading to a 59 basepair insertion and chain termination. The four families wrth both breast and ovarian cancer had chain termination mutations in the N-terminal half of the protein.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Miki, Y. et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266, 66–71 (1994).
Hall, J.M. et al. Linkage of early-onset familial breast cancer to chromosome 17q21. Science 250, 1684–1689 (1990).
Albertsen, H.M. et al. A physical map and candidate genes in the BRCA1 region on chromosome 17q12–21. Nature Genet. 7, 472–479 (1994).
Sharp, P.A. Split genes and RNA splicing. Cell 77, 805–815. (1994).
Friedman, L.S. et al. The search for BRCA1 and the cloning of 22 genes from chromosome 17q21. Cancer Res. (in the press).
American Society of Human Genetics. Statement on genetic testing for breast and ovarian cancer. Am. J. hum. Genet. 55, 860 (1994).
Rowell, S., Newman, B., Boyd, J. & King, M-C. Inherited predisposition to breast and ovarian cancer. Am. J. hum. Genet. 55, 861–865 (1994).
Arena, J.F. et al. Inherited breast cancer: Confirmation of linkage to BRCA2, possible linkage to the estrogen receptor, and the clinical implications of genetic complexity. J. Am. med. Assoc. (in the press).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Friedman, L., Ostermeyer, E., Szabo, C. et al. Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families. Nat Genet 8, 399–404 (1994). https://doi.org/10.1038/ng1294-399
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ng1294-399
This article is cited by
-
Synthesis and characterization of some benzidine-based azomethine derivatives with molecular docking studies and anticancer activities
Chemical Papers (2023)
-
Genomic structural variation in tomato and its role in plant immunity
Molecular Horticulture (2022)
-
Mechanisms of BRCA1–BARD1 nucleosome recognition and ubiquitylation
Nature (2021)
-
BRCA1 and BRCA2 genes mutations among high risk breast cancer patients in Jordan
Scientific Reports (2020)
-
Design, Synthesis and Interaction of BRCA1 Peptide Fragments with RAD51(181–200)
International Journal of Peptide Research and Therapeutics (2020)
